SMSbiotech Leadership Team

Ghassan Kassab, PhD.
Chief Executive Officer (Interim)

Has extensive experience in promoting hands-on startups of Life Science companies. He has founded and currently runs a nonprofit research center, The California Medical Innovations Institute. He has published over 600 proceedings, abstracts, and full-length publications, and has over 300 issued or pending patents. His current Intellectual properties have resulted in a sale of one technology, six ongoing start-ups, and four exclusive licenses to the major medical device industry.

Abdulkader Rahmo, PhD
Co-Founder, President, Chief Scientific Officer

Bachelor in biochemistry from the Swiss Federal Institute of Technology (ETH) in Zurich; Ph.D. in Biochemistry from the University of Southern California (USC) in Los Angeles and postdoc at a major clinical laboratory in Munich Germany. As a former associate professor, he has over 30 years of experience in basic and applied research; 11 years primarily focused on SMS cell discovery, development, and technology. Experienced in clinical laboratory medicine, GXP compliance, and biomanufacturing. Co-Founded and lead several private and public entities including the National Commission for Biotechnology where he became the head of the medical Biotechnology section.

Harry Friedman
Chief Financial Officer

Seasoned Businessman, Investor, and Consultant Experienced Board Member. Self-financed a high-growth technology company which successfully sold, 20-plus years later, to a large conglomerate. Started and participated in growing and selling several technology companies. Was a long-time member of Tech Coast Angels.

Advisors

Prof. James Sherley, MD

Former Associate Professor at MIT (nine years), founder and former director of the Adult Stem Cell Technology Center at the Boston Biomedical Research Institute (five years); currently founder and Director of Asymmetrex, LLC, Adjunct Associate Professor, Hematology-Oncology Department, Rhode Island Hospital Brown University.

Patrick Griffith, MD, MBA

Exec. Medical Director at Adventist Health, Heart & Vascular Institute. +25 yrs as Cardiac & Thoracic Surgeon. Served as Medical Director of Thoracic Surgery for Salinas Valley Healthcare Systems and Chief of Cardiac Surgery at Rideout Medical Center. Leonhardt Ventures Board Director, Board Member for Second Heart Assist, Stimcoremd, and Beall Center for Innovation & Entrepreneurship. UCI Dean’s Advisory Board Member.

Gary Sieck, Ph.D.

Prof. of Physiology at Mayo Clinic School of Medicine and Science. Studies focus on cell signaling mechanisms that underlie muscle performance, with a focus on regenerative processes that can improve acute and chronic disease conditions. He has published over 380 peer-reviewed papers and received multiple NIH grants over 37+ years.

Roger Schechter, MD

FACEP, FCCWS, UHM-ABEM, Medical Director for Wound Management at Palomar Health San Diego, Chief Medical Officer at Synergy Wound Technology, trained in Emergency Medicine, practices full time as a Wound Care and Hyperbaric Medicine Physician, a national level speaker on wound care, advanced wound care modalities, and non-invasive vascular testing.

Prof. Peter Wagner, MD

Emeritus Prof. at UCSD, leader in Respiratory Physiology, served as the Pres. of the American Thoracic Society, Pres. of the American Physiological Society, and Division Chief of both Physiology and Pulmonary Critical Care at UCSD School of Medicine, and as both member and chair of National Institutes of Health study sections.

Board of Directors

Joe Kiani
Co-founder and CEO of Masimo Corp.

Mohamed Diab
Cofounder and Sr Research Scientist of Masimo Corp.

Harry Friedman
Serial Entrepreneur, Investor

Ghassan Kassab, PhD
Founder/President/CSO of California Medical Innovations Institute

Abdulkader Rahmo, PhD.
Co-Founder, President, CSO of SMSbiotech